within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BD28_MetforminAndTeneliglipti;

model MetforminAndTeneliglipti
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.55,
    Cl = 2.0833333333333333e-05,
    adminDuration = 600,
    adminMass = 500 / 1000000,
    adminCount = 1,
    Vd = 0.06,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0010333333333333334,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>MetforminAndTeneligliptin</td></tr><tr><td>ATC code:</td><td>A10BD28</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>60</td><td>L</td></tr>
    <tr><td>clearance:</td><td>75</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Metformin and teneligliptin is a fixed dose combination of two antidiabetic agents: metformin, a biguanide that reduces hepatic glucose production and increases insulin sensitivity, and teneligliptin, a DPP-4 inhibitor that increases incretin levels and glucose-dependent insulin secretion. This combination is approved and widely used for the treatment of type 2 diabetes mellitus in adults to improve glycemic control.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for typical adult population receiving the fixed-dose combination orally. No primary published population pharmacokinetic (PopPK) models for the combination product found; parameters are based on known monotherapy PK data and fixed dose combination prescribing information.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A10BD28 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end MetforminAndTeneliglipti;
